Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07158658 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 2v5
  2. Primary completion date: Mar 1, 2026 to Dec 1, 2026
    • Study completion date: May 1, 2026 to Jan 1, 2027
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 13, 2025 to Dec 1, 2025
    • Site details revised
    v3
  4. Start date: Oct 1, 2025 to Nov 13, 2025
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers
Trial Details
NCT Number NCT07158658
Lead Sponsor NuScience Medical Biologics, LLC
Collaborators: SygNola, LLC
Conditions
(from sponsor)		 Pressure Injury
Related terms Pressure Ulcer
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov